Porphyrin Derivatives-Mediated Sonodynamic Therapy forMalignant Gliomas InVitro

Ultrasound in Medicine and Biology

Volumn 41, Issue 9, 2015, Pages 2458-2465

  Endo, Shogo ^a   Kudo, Nobuki ^b   Yamaguchi, Shigeru ^a   Sumiyoshi, Koki ^b   Motegi, Hiroaki ^a   Kobayashi, Hiroyuki ^a   Terasaka, Shunsuke ^a   Houkin, Kiyohiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

5 Aminolevulinic acid; Invitro; Malignant glioma; Porphyrin derivatives; Protoporphyrin IX; Sonodynamic therapy; Talaporfin sodium; Ultrasound

Indexed keywords

CELL DEATH; CELLS; CYTOLOGY; CYTOTOXICITY; DIAGNOSIS; PORPHYRINS; SODIUM; ULTRASONICS;

5-AMINOLEVULINIC ACID; IN-VITRO; MALIGNANT GLIOMA; PORPHYRIN DERIVATIVES; PROTOPORPHYRIN IX; SONODYNAMIC THERAPY;

TUMORS;

AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN; SONOSENSITIZER; TALAPORFIN; UNCLASSIFIED DRUG; PORPHYRIN; RADIOSENSITIZING AGENT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SONODYNAMIC THERAPY; ULTRASOUND THERAPY; ANIMAL; BRAIN NEOPLASMS; ECHOGRAPHY; GLIOMA; HIGH INTENSITY FOCUSED ULTRASOUND; PATHOLOGY; PROCEDURES; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOMA; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; PORPHYRINS; RADIATION-SENSITIZING AGENTS; RATS; TREATMENT OUTCOME;

EID: 84938210788     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2015.05.007     Document Type: Article

References (32)

1. Canaparo R., Serpe L., Catalano M.G., Bosco O., Zara G.P., Berta L., Frairia R. High energy shock waves (HESW) for sonodynamic therapy: Effects on HT-29 human colon cancer cells. Anticancer Res 2006, 26:3337-3342.
2. Chen H., Zhou X., Gao Y., Zheng B., Tang F., Huang J. Recent progress in development of new sonosensitizers for sonodynamic cancer therapy. Drug Discov Today 2014, 19:502-509.
3. Cheng J., Sun X., Guo S., Cao W., Chen H., Jin Y., Li B., Li Q., Wang H., Wang Z., Zhou Q., Wang P., Zhang Z., Cao W., Tian Y. Effects of 5-aminolevulinic acid-mediated sonodynamic therapy on macrophages. Int J Nanomedicine 2013, 8:669-676.
4. Chinot O.L., Wick W., Mason W., Henriksson R., Saran F., Nishikawa R., Carpentier A.F., Hoang-Xuan K., Kavan P., Cernea D., Brandes A.A., Hilton M., Abrey L., Cloughesy T. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. NEngl J Med 2014, 370:709-722.
5. Feng Y., Tian Z., Wan M. Bioeffects of low-intensity ultrasound invitro: Apoptosis, protein profile alteration, and potential molecular mechanism. JUltrasound Med 2010, 29:963-974.
6. Gilbert M.R., Dignam J.J., Armstrong T.S., Wefel J.S., Blumenthal D.T., Vogelbaum M.A., Colman H., Chakravarti A., Pugh S., Won M., Jeraj R., Brown P.D., Jaeckle K.A., Schiff D., Stieber V.W., Brachman D.G., Werner-Wasik M., Tremont-Lukats I.W., Sulman E.P., Aldape K.D., Curran W.J., Mehta M.P. Arandomized trial of bevacizumab for newly diagnosed glioblastoma. NEng J Med 2014, 370:699-708.
7. Ishizuka M., Abe F., Sano Y., Takahashi K., Inoue K., Nakajima M., Kohda T., Komatsu N., Ogura S., Tanaka T. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. Int Immunopharmacol 2011, 11:358-365.
8. Jeong E.J., Seo S.J., Ahn Y.J., Choi K.H., Kim K.H., Kim J.K. Sonodynamically induced antitumor effects of 5-aminolevulinic acid and fractionated ultrasound irradiation in an orthotopic rat glioma model. Ultrasound Med Biol 2012, 38:2143-2150.
9. Lagneaux L., de Meulenaer E.C., Delforge A., Dejeneffe M., Massy M., Moerman C., Hannecart B., Canivet Y., Lepeltier M.F., Bron D. Ultrasonic low-energy treatment: A novel approach to induce apoptosis in human leukemic cells. Exp Hematol 2002, 30:1293-1301.
10. Li Y., Wang P., Zhao P., Zhu S., Wang X., Liu Q. Apoptosis induced by sonodynamic treatment by protoporphyrin IX on MDA-MB-231 cells. Ultrasonics 2012, 52:490-496.
11. Lipsman N., Mainprize T.G., Schwartz M.L., Hynynen K., Lozano A.M. Intracranial applications of magnetic resonance-guided focused ultrasound. Neurotherapeutics 2014, 11:593-605.
12. Lv Y., Fang M., Zheng J., Yang B., Li H., Xiuzigao Z., Song W., Chen Y., Cao W. Low-intensity ultrasound combined with 5-aminolevulinic acid administration in the treatment of human tongue squamous carcinoma. Cell Physiol Biochem 2012, 30:321-333.
13. McDannold N., Clement G.T., Black P., Jolesz F., Hynynen K. Transcranial magnetic resonance imaging-guided focused ultrasound surgery of brain tumors: Initial findings in 3 patients. Neurosurgery 2010, 66:323-332.
14. Miyatake S., Kawabata S., Hiramatsu R., Furuse M., Kuroiwa T., Suzuki M. Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: Four cases. Radiat Oncol 2014, 9:6.
15. Muragaki Y., Akimoto J., Maruyama T., Iseki H., Ikuta S., Nitta M., Maebayashi K., Saito T., Okada Y., Kaneko S., Matsumura A., Kuroiwa T., Karasawa K., Nakazato Y., Kayama T. Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. JNeurosurg 2013, 119:845-852.
16. Nakamura H., Makino K., Yano S., Kuratsu J. Kumamoto Brain Tumor Research Group. Epidemiological study of primary intracranial tumors: A regional survey in Kumamoto prefecture in southern Japan-20-year study. Int J Clin Oncol 2011, 16:314-321.
17. Ohmura T., Fukushima T., Shibaguchi H., Yoshizawa S., Inoue T., Kuroki M., Sasaki K., Umemura S. Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat. Anticancer Res 2011, 31:2527-2533.
18. Ram Z., Cohen Z.R., Harnof S., Tal S., Faibel M., Nass D., Maier S.E., Hadani M., Mardor Y. Magnetic resonance imaging-guided, high-intensity focused ultrasound for brain tumor therapy. Neurosurgery 2006, 59:949-955.
19. Report of Brain Tumor Registry of Japan (2001-2004), 13th ed. Neurol Med Chir (Tokyo) 2014, 54(Suppl 1):1-102.
20. Rosenthal I., Sostaric J.Z., Riesz P. Sonodynamic therapy: A review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 2004, 11:349-363.
21. Song W., Cui H., Zhang R., Zheng J., Cao W. Apoptosis of SAS cells induced by sonodynamic therapy using 5-aminolevulinic acid sonosensitizer. Anticancer Res 2011, 31:39-45.
22. Stylli S.S., Kaye A.H. Photodynamic therapy of cerebral glioma-A review:Part I. A biological basis. JClin Neurosci 2006, 13:615-625.
23. Stylli S.S., Kaye A.H. Photodynamic therapy of cerebral glioma-a review: Part II. Clinical studies. JClin Neurosci 2006, 13:709-717.
24. Su X., Li Y., Wang P., Wang X., Liu Q. Protoporphyrin IX-mediated sonodynamic action induces apoptosis of K562 cells. Ultrasonics 2014, 54:275-284.
25. Thomas A.A., Brennan C.W., DeAngelis L.M., Omuro A.M. Emerging therapies for glioblastoma. JAMA Neurol 2014, 71:1437-1444.
26. Wang X., Wang P., Tong W., Liu Q. Comparison of pharmacokinetics, intracellular localizations and sonodynamic efficacy of endogenous and exogenous protoporphyrin IX in sarcoma 180 cells. Ultrasonics 2010, 50:803-810.
27. Wilson C.B. Glioblastoma: The past, the present, and the future. Clin Neurosurg 1992, 38:32-48.
28. Xu Z.Y., Wang K., Li X.Q., Chen S., Deng J.M., Cheng Y., Wang Z.G. The ABCG2 transporter is a key molecular determinant of the efficacy of sonodynamic therapy with Photofrin in glioma stem-like cells. Ultrasonics 2013, 53:232-238.
29. 2-polyethylene glycol compound on glioma cells: Comparison of cytotoxic mechanism with photodynamic therapy. Ultrason Sonochem 2011, 18:1197-1204.
30. Yumita N., Iwase Y., Nishi K., Ikeda T., Komatsu H., Fukai T., Onodera K., Nishi H., Takeda K., Umemura S., Okudaira K., Momose Y. Sonodynamically-induced antitumor effect of mono-l-aspartyl chlorin e6 (NPe6). Anticancer Res 2011, 31:501-506.
31. Yumita N., Okudaira K., Momose Y., Umemura S. Sonodynamically induced apoptosis and active oxygen generation by gallium-porphyrin complex, ATX-70. Cancer Chemother Pharmacol 2010, 66:1071-1078.
32. Zhang Z., Chen J., Chen L., Yang X., Zhong H., Qi X., Bi Y., Xu K. Low frequency and intensity ultrasound induces apoptosis of brain glioma in rats mediated by caspase-3, Bcl-2, and survivin. Brain Res 2012, 1473:25-34.